About this trial
This study aims to improve health outcomes for people who use drugs after release from incarceration, a period of high risk for overdose and other adverse outcomes. It will examine an individually tailored behavioral activation (IT-BA) intervention integrated into a reentry primary care program with peer support. The goal is to reduce substance use, improve mental health, and increase engagement in healthcare.
Eligibility criteria
Qualifiers
Be aged 18 years or older
Have recent illicit drug use, defined as use of any illegal drug in the past week
Meet DSM-5 criteria for a current (past 12 months) substance use disorder associated with any illegal drug
Have been released from jail or prison (at least 30 consecutive days incarcerated) within the past year
Disqualifiers
Currently engaged in psychosocial treatment for drug use
Unable to speak and understand English
Unable to provide informed consent, including people with severe mental illness requiring immediate treatment or with mental illness limiting their ability to participate (e.g., dementia)
Trial design
Treatments tested in this trial
- Individually Tailored Behavioral Activation
- Formerly Incarcerated Transitions Program
Treatment groups
Locations
Sponsors and collaborators
Catherine E. Paquette, PhD
Lead sponsor
Duke University
Sponsor institution
National Institute on Drug Abuse (NIDA)
Collaborator